Aakash Desai, MBBS

Aakash Desai practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Aakash Desai's NPI, 1023543451, was assigned on April 24, 2017. Aakash Desai holds Minnesota license 68096.

Aakash Desai's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Aakash Desai's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Aakash Desai is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Aakash Desai to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aakash Desai practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Aakash Desai's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Aakash Desai is board certified in hematology by the American Board of Internal Medicine. Aakash Desai is licensed in Minnesota.

CMS data shows 333 Medicare services from Aakash Desai across 4 procedure codes in 2024, for 91 Medicare patients. Medicare paid $21,531 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Aakash Desai in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aakash Desai's median patient age at 68, with 49% women.

In 2024, Aakash Desai wrote 548 Medicare Part D claims for 104 patients. 84% of them were for generic drugs. CMS names the drug for 390 of them, across 15 drugs with 11 or more claims each, at $316,493 in total drug cost. In 2023, CMS named 54 claims across 4 drugs.

Aakash Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Aakash Desai as offering telehealth.

CMS Open Payments shows 61 general payments to Aakash Desai from 17 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $10,106. It also lists 2 research payments totaling $950 in 2025.